#ICYMI A replay of the C-FIT (Cellvizio® Food Intolerance Test) webinar is now available to view. Watch to gain more insight into the clinical benefits of using #Cellvizio for your IBS patients & the value of working with registered dietitians. hubs.la/Q02tMMx20

Discover C-FIT, #Cellvizio Food Intolerance Testing, during our webinar happening in 2 weeks featuring speakers Prof. Jost Langhorst, MD, a C-FIT expert, & @BethRosenRD, an authority in nutrition intervention! Click the link to register: share.hsforms.com/1xDz67jhZRbOB1… #gitwitter #IBS

Tune into our webinar tomorrow to learn about the #Cellvizio Food Intolerance Test (C-FIT) featuring Prof. Jost Langhorst, MD, renowned in the C-FIT diagnostic method, & @BethRosenRD, an expert in nutrition intervention! Click to register: share.hsforms.com/1xDz67jhZRbOB1… #GITwitter

BE is the only known precursor of EAC, thus adequate surveillance EGD procedures are vital to avoid the progression to more serious disease states. During #EsophagealCancerAwarenessMonth, discover the power of an early & accurate diagnosis with #Cellvizio: hubs.ly/Q02sxttg0

Pulmonary alveolar proteinosis (PAP) is a rare lung disease where surfactant proteins build up in the lungs. This study highlights how pCLE can detect PAP even in mild cases, which may help avoid invasive biopsies. hubs.la/Q02qbWtF0 #Cellvizio #AdvancedImaging

Within this case report, the atypical presentation of gastric adenocarcinoma highlights the importance of accurate diagnosis and the potential of #advancedimaging techniques like #Cellvizio for early detection. Read the full publication: hubs.la/Q02mddgm0 #GastricCancer

Via @Medscape, #PancreaticCancer rates are skyrocketing in Europe. Often undetected until it’s too late, early diagnosis is crucial. #Cellvizio can classify & risk strategy pancreatic cystic lesions more accurately than traditional methods. hubs.la/Q02lPDWV0

Today we announce the results of Q4 & FY 2023 sales, up +42% vs 2022, highlighting record-high PPU (pay-per-use) growth of +109% in Q4 2023 with FY PPU growth of +57%, strategic investment from Telix Pharmaceuticals, & launch of Tasly JV. hubs.la/Q02hPYF30 #Cellvizio $ALMKT

Fine-tuning your image pattern recognition skills is just one of the many pursuits to enjoy on the free #Cellvizio app. This tool is consistently updated with new content, Cellvizio case studies, & quizzes to test your knowledge. Available for iOS or Android devices. #MobileApp

Physicians, there's no time like the new year to reconsider what technologies will best support your patient management in the coming months. Make the most of your New Year’s resolution and consider how #Cellvizio could revolutionize your practice: hubs.la/Q02fyMcw0

Telix Pharmaceuticals and Mauna Kea Technologies join forces to develop advanced hybrid pharmaceutical-device products for precision surgery in urology. #Radiopharmaceuticals #Cellvizio #UrologicOncology #PrecisionMedicine #Telix #MaunaKea #IRiSAlliance

The free #Cellvizio app is easy to use, from anywhere. Enhance your image pattern recognition skills and use samples from our video library as references to compare your cases with examples from a wide range of indications. #Gastroenterology #Pulmonology #CellularImaging

Crohn’s Disease & Ulcerative Colitis are two chronic inflammatory bowel diseases (#IBD) affecting millions around the world. Learn how #Cellvizio can be superior to conventional severity scoring: hubs.la/Q02bCG1P0 #CrohnsAndColitisAwarenessWeek #IBDvisible

#CommuniquéDePresse 🗞️ @maunakeatech annonce le recrutement du 1er patient dans le cadre de l'étude clinique CLEVER sur le cancer du poumon périphérique en collaboration avec l’Amsterdam UMC $MKEA #medtech #IA #Cellvizio

Congrats Dr. Rayapudi & staff at Hilliard Endo Center, associated w/ @gastrooffice, for being @EndoProMag's All Stars! They seamlessly integrated #Cellvizio into normal operating procedures, demonstrating ease of use & the team's commitment to working together. #healthservices

#CommuniquéDePresse 🗞️ @maunakeatech annonce une croissance de son chiffre d’affaires de 74% sur les 9 premiers mois de 2023 $MKEA #medtech #IA #Cellvizio #finance

#Interview 🎥 @sachaloiseau est l'invité du Journal des Biotechs. Dans cette interview, le PDG de @maunakeatech revient sur les résultats récemment publiés et ses ambitions pour les mois à venir (à partir de 13:10 min) $ALMKT #medtech #IA #Cellvizio #imagerie

3 Questions à Mauna Kea Technologies 🎤 @sachaloiseau, PDG de @maunakeatech, revient sur la publication des résultats semestriels 2023 et les perspectives de la société Vidéo entière : youtu.be/InEZTvRayU8 $MKEA #medtech #IA #Cellvizio

#CommuniquéDePresse 🗞️ @maunakeatech publie ses résultats du premier semestre 2023 $MKEA #medtech #IA #Cellvizio #finance

#CommuniquéDePresse 🗞️ @maunakeatech et l'Institut d'Endoscopie d'Hawaï franchissent le cap des 1 200 procédures Cellvizio pour le diagnostic et le traitement interventionnel de maladies gastriques Plus d'infos : maunakeatech.com/fr/actualites/… $MKEA #medtech #IA #Cellvizio